OTTAWA — Pharmaceutical company Moderna says the federal government has purchased 12 million doses of the company’s bivalent vaccine that targets both the original strain of COVID-19 and the Omicron variant.
Canada has purchased 4.5 million new doses and moved up the delivery date for the 1.5 million doses originally due to arrive in Canada next year.
The government and the US pharmaceutical company have also agreed to convert six million doses of the original Spikevax COVID-19 vaccine to bivalent doses.
The deal is contingent on Health Canada approving the bivalent vaccine, which was submitted for review on June 30.
Last week, UK regulators were the first in the world to authorize Moderna’s vaccine which protects against both the original strain of coronavirus and the Omicron BA.1 subvariant.
Health Canada is also reviewing a proposal from Pfizer for a bivalent Omicron vaccine.